[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Incorporated(NasdaqGS: VRTX) dropped from Russell 3000E Value Index",
    "summary": "Vertex Pharmaceuticals Incorporated dropped from Russell 3000E Value Index...",
    "url": "https://finnhub.io/api/news?id=f72426b62cd3bccaeb88a41f5a83847be57a9bf20452e3e075b57f80498fdb45",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751238985,
      "headline": "Vertex Pharmaceuticals Incorporated(NasdaqGS: VRTX) dropped from Russell 3000E Value Index",
      "id": 135635920,
      "image": "",
      "related": "VRTX",
      "source": "Finnhub",
      "summary": "Vertex Pharmaceuticals Incorporated dropped from Russell 3000E Value Index...",
      "url": "https://finnhub.io/api/news?id=f72426b62cd3bccaeb88a41f5a83847be57a9bf20452e3e075b57f80498fdb45"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Incorporated(NasdaqGS: VRTX) dropped from Russell 3000 Value Index",
    "summary": "Vertex Pharmaceuticals Incorporated dropped from Russell 3000 Value Index...",
    "url": "https://finnhub.io/api/news?id=c0db11964e932210d450d9e4bff631675b06af9fdd92004cf65ee47fe0897718",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751238757,
      "headline": "Vertex Pharmaceuticals Incorporated(NasdaqGS: VRTX) dropped from Russell 3000 Value Index",
      "id": 135635909,
      "image": "",
      "related": "VRTX",
      "source": "Finnhub",
      "summary": "Vertex Pharmaceuticals Incorporated dropped from Russell 3000 Value Index...",
      "url": "https://finnhub.io/api/news?id=c0db11964e932210d450d9e4bff631675b06af9fdd92004cf65ee47fe0897718"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Incorporated(NasdaqGS: VRTX) dropped from Russell Top 200 Value Index",
    "summary": "Vertex Pharmaceuticals Incorporated dropped from Russell Top 200 Value Index...",
    "url": "https://finnhub.io/api/news?id=01554437a9a824d50eb353de4d6664420f705377647cb600c9f28c81093d0863",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751232346,
      "headline": "Vertex Pharmaceuticals Incorporated(NasdaqGS: VRTX) dropped from Russell Top 200 Value Index",
      "id": 135634360,
      "image": "",
      "related": "VRTX",
      "source": "Finnhub",
      "summary": "Vertex Pharmaceuticals Incorporated dropped from Russell Top 200 Value Index...",
      "url": "https://finnhub.io/api/news?id=01554437a9a824d50eb353de4d6664420f705377647cb600c9f28c81093d0863"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Incorporated(NasdaqGS: VRTX) dropped from Russell 1000 Value Index",
    "summary": "Vertex Pharmaceuticals Incorporated dropped from Russell 1000 Value Index...",
    "url": "https://finnhub.io/api/news?id=cbecbf3b3f1071250511084c4383419ff8bb295640f6dce3cdebd607de144b80",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751232150,
      "headline": "Vertex Pharmaceuticals Incorporated(NasdaqGS: VRTX) dropped from Russell 1000 Value Index",
      "id": 135634305,
      "image": "",
      "related": "VRTX",
      "source": "Finnhub",
      "summary": "Vertex Pharmaceuticals Incorporated dropped from Russell 1000 Value Index...",
      "url": "https://finnhub.io/api/news?id=cbecbf3b3f1071250511084c4383419ff8bb295640f6dce3cdebd607de144b80"
    }
  },
  {
    "ts": null,
    "headline": "H.C. Wainwright Reaffirms Vertex Buy Rating After ADA Conference Results",
    "summary": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best fundamental stocks to buy according to hedge funds. With a price target of $550, H.C. Wainwright reaffirmed its Buy rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on June 23. The update comes after the American Diabetes Association (ADA) conference featured updated data from Vertex’s zimislecel program. According to […]",
    "url": "https://finnhub.io/api/news?id=903a418494cfa1e53a1ae5274830375d769d62e2b8c772e91e5714bea77bbfb3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751216022,
      "headline": "H.C. Wainwright Reaffirms Vertex Buy Rating After ADA Conference Results",
      "id": 135640038,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best fundamental stocks to buy according to hedge funds. With a price target of $550, H.C. Wainwright reaffirmed its Buy rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on June 23. The update comes after the American Diabetes Association (ADA) conference featured updated data from Vertex’s zimislecel program. According to […]",
      "url": "https://finnhub.io/api/news?id=903a418494cfa1e53a1ae5274830375d769d62e2b8c772e91e5714bea77bbfb3"
    }
  }
]